These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36054347)

  • 1. The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI Study.
    Bogdanet D; Luque-Fernandez MA; Toth-Castillo M; Desoye G; O'Shea PM; Dunne FP; Halperin JA
    J Clin Endocrinol Metab; 2022 Nov; 107(11):e4311-e4319. PubMed ID: 36054347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.
    Ma D; Luque-Fernandez MA; Bogdanet D; Desoye G; Dunne F; Halperin JA;
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1033-40. PubMed ID: 32069353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland.
    Bogdanet D; Toth Castillo M; Doheny H; Dervan L; Angel Luque-Fernandez M; Halperin J; O'Shea PM; Dunne FP
    Diabetes Res Clin Pract; 2022 Aug; 190():110023. PubMed ID: 35907507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.
    Bogdanet D; Castillo MT; Doheny H; Dervan L; Luque-Fernandez MA; Halperin JA; O'Shea PM; Dunne FP
    Acta Diabetol; 2023 Feb; 60(2):211-223. PubMed ID: 36309618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.
    Bogdanet D; Toth Castillo M; Doheny H; Dervan L; Luque-Fernandez MA; Halperin JA; O'Shea PM; Dunne FP
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol.
    Andrews C; Toth-Castillo M; Aktas H; Fernandez ML; Wong SK; Sen S; Halperin J
    BMJ Open; 2022 Apr; 12(4):e054773. PubMed ID: 35443950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening.
    Bogdanet D; Castillo MT; Doheny H; Dervan L; Luque-Fernandez MA; Halperin J; O'Shea PM; Dunne FP
    Diabet Med; 2023 Sep; 40(9):e15121. PubMed ID: 37078256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between maternal blood lipids and neonatal hypoglycaemia in pregnancy with gestational diabetes mellitus: a cohort study.
    Zhang M; Huang X; Lin S; Liu B
    Lipids Health Dis; 2024 Jun; 23(1):170. PubMed ID: 38849832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes.
    Benhalima K; Ma DD; Laenen A; Mathieu C; Halperin JA
    Eur J Endocrinol; 2021 Oct; 185(5):755-763. PubMed ID: 34524975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Quantose Insulin Resistance Test for Maternal Insulin Resistance: A Pilot Study.
    Eid J; Kechichian T; Benavides E; Thibodeaux L; Salazar AE; Saade GR; Saad AF
    Am J Perinatol; 2022 Apr; 39(5):513-518. PubMed ID: 32894869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially modifiable predictors of adverse neonatal and maternal outcomes in pregnancies with gestational diabetes mellitus: can they help for future risk stratification and risk-adapted patient care?
    Antoniou MC; Gilbert L; Gross J; Rossel JB; Fischer Fumeaux CJ; Vial Y; Puder JJ
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):469. PubMed ID: 31801465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal body mass index is a predictor of neonatal hypoglycemia in gestational diabetes mellitus.
    García-Patterson A; Aulinas A; María MÁ; Ubeda J; Orellana I; Ginovart G; Adelantado JM; de Leiva A; Corcoy R
    J Clin Endocrinol Metab; 2012 May; 97(5):1623-8. PubMed ID: 22419709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers.
    Schaefer-Graf UM; Rossi R; Bührer C; Siebert G; Kjos SL; Dudenhausen JW; Vetter K
    Am J Obstet Gynecol; 2002 Oct; 187(4):913-7. PubMed ID: 12388976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance.
    Ghosh P; Luque-Fernandez MA; Vaidya A; Ma D; Sahoo R; Chorev M; Zera C; McElrath TF; Williams MA; Seely EW; Halperin JA
    Diabetes Care; 2017 Jul; 40(7):981-984. PubMed ID: 28450368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
    Yang YD; Zhai GR; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcomes for neonatal hypoglycaemia and neonatal hyperbilirubinaemia in pregnancies complicated by gestational diabetes mellitus: a single centre retrospective 3-year review.
    Thevarajah A; Simmons D
    Diabet Med; 2019 Sep; 36(9):1109-1117. PubMed ID: 30972790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe threshold of capillary blood glucose for predicting early future neonatal hypoglycaemia in babies born to mothers with gestational diabetes mellitus, an observational, retrospective cohort study.
    Park EHG; O'Brien F; Seabrook F; Hirst JE
    BMC Pregnancy Childbirth; 2021 Jul; 21(1):499. PubMed ID: 34243753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of neonatal hypoglycemia in neonates born to mothers with gestational diabetes.
    Arimitsu T; Kasuga Y; Ikenoue S; Saisho Y; Hida M; Yoshino J; Itoh H; Tanaka M; Ochiai D
    Endocr J; 2023 May; 70(5):511-517. PubMed ID: 36792172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational diabetes among Saudi women: prevalence, risk factors and pregnancy outcomes.
    Alfadhli EM; Osman EN; Basri TH; Mansuri NS; Youssef MH; Assaaedi SA; Aljohani BA
    Ann Saudi Med; 2015; 35(3):222-30. PubMed ID: 26409797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a prediction model for neonatal hypoglycemia risk factors: a retrospective study.
    Wu T; Huang YY; Song W; Redding SR; Huang WP; Ouyang YQ
    Front Endocrinol (Lausanne); 2023; 14():1199628. PubMed ID: 37529595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.